David H. Altreuter

Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance

Roberto Maldonado, Robert A. LaMothe, Joseph D. Ferrari et al. · Proceedings of the National Academy of Sciences · 2014 · 421 citations · Full text

Nanoparticles, Engineering, Current Treatments +22

Improving the efficacy and safety of biologic drugs with tolerogenic nanoparticles

Takashi Kishimoto, Joseph D. Ferrari, Robert A. LaMothe et al. · Nature Nanotechnology · 2016 · 186 citations

Nanoparticles, Engineering, Therapeutic Nanomaterials +5

Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release

Petr O. Ilyinskii, Chad J. Roy, Conlin P. O’Neil et al. · Vaccine · 2014 · 160 citations · Full text

Generation of a universal CD4 memory T cell recall peptide effective in humans, mice and non-human primates

Christopher C. Fraser, David H. Altreuter, Petr O. Ilyinskii et al. · Vaccine · 2014 · 81 citations · Full text

T-regulatory Cell, Immunology, Cd4t Cells +16

Development and preclinical evaluation of SEL-068, a novel <i>targeted</i> Synthetic Vaccine Particle ( <i>t</i> SVP™) for smoking cessation and relapse prevention that generates high titers of antibodies against nicotine (75.11)

Lynnelle A. Pittet, David H. Altreuter, Petr O. Ilyinskii et al. · The Journal of Immunology · 2012 · 16 citations